קואט DVI 500

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

FACTOR VIII (HUMAN)

Disponible depuis:

PADAGIS ISRAEL AGENCIES LTD, ISRAEL

Code ATC:

B02BD02

forme pharmaceutique:

אבקה להכנת תמיסה לזריקה

Composition:

FACTOR VIII (HUMAN) 500 IU/VIAL

Mode d'administration:

תוך-ורידי

Type d'ordonnance:

מרשם נדרש

Fabriqué par:

GRIFOLS THERAPEUTICS LLC., USA

Groupe thérapeutique:

COAGULATION FACTOR VIII

Domaine thérapeutique:

COAGULATION FACTOR VIII

indications thérapeutiques:

For the treatment of classical hemophilia (hemophilia A) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor VIII . Koate-DVI provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.

Date de l'autorisation:

2015-02-28